Bitter gourd (Momordica charantia) extract activates peroxisome proliferator-activated receptors and upregulates the expression of the acyl CoA oxidase gene in H4IIEC3 hepatoma cells

Journal of Biomedical Science

Volumn 10, Issue 6 II, 2003, Pages 782-791

  Chao, Che Yi ^a   Huang, Ching Jang ^a  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

Bitter gourd; Hypolipidemic; Peroxisome proliferator activated receptor ; Stable transfection

Indexed keywords

ACETIC ACID ETHYL ESTER; ACYL COENZYME A OXIDASE; ALKALINE PHOSPHATASE; FATTY ACID BINDING PROTEIN; MESSENGER RNA; MOMORDICA CHARANTIA EXTRACT; ORGANIC SOLVENT; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PIRINIXIC ACID; RECOMBINANT RECEPTOR; ROSIGLITAZONE; TRANSCRIPTION FACTOR GAL4;

ANIMAL CELL; ARTICLE; CELL ASSAY; CELL CLONING; CHIMERA; CHINESE HAMSTER; CONTROLLED STUDY; DOSE RESPONSE; ENZYME ACTIVITY; FOOD; FRUIT; GENE EXPRESSION; GENETIC TRANSFECTION; HEPATOMA CELL; LIGAND BINDING; MOMORDICA CHARANTIA; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REPORTER GENE; SCREENING; SOLUBILITY; TRANSACTIVATION; UPREGULATION; VEGETABLE;

ACYL-COA OXIDASE; ANALYSIS OF VARIANCE; ANIMALS; BLOTTING, NORTHERN; CELL LINE, TUMOR; GENE EXPRESSION REGULATION; GENES, REPORTER; MICE; MOMORDICA CHARANTIA; PLANT EXTRACTS; RECEPTORS, CYTOPLASMIC AND NUCLEAR; SIGNAL TRANSDUCTION; TRANS-ACTIVATION (GENETICS); TRANSCRIPTION FACTORS; TRANSFECTION;

CUCURBITA; MOMORDICA; MOMORDICA CHARANTIA; MURINAE;

EID: 0347418244     PISSN: 10217770     EISSN: 14230127     Source Type: Journal    
DOI: 10.1159/000073966     Document Type: Article

References (44)

1. Ahmed I, Adeghate E, Sharma AK, Pallot DJ, Singh J. Effects of Momordica charantia fruit juice on islet morphology in the pancreas of the streptozotocin-diabetic rat. Diabetes Res Clin Pract 40:145-151;1998.
2. Akhtar MS, Athar MA, Yaqub M. Effect of Momordica charantia on blood glucose level of normal and alloxan-diabetic rabbits. Planta Med 42:205-212;1981.
3. BarTana J. Peroxisome proliferator-activated receptor gamma (PPARγ) activation and its consequences in humans. Toxicol Lett 120:9-19;2001.
4. Belury MA. Dietary conjugated linoleic acid in health: Physiological effects and mechanisms of action. Annu Rev Nutr 22:505-531;2002.
5. 450 4A1 genes in rats and activates PPARα. J Nutr 131:3166-3174; 2001.
6. Chen Q, Chan LLY, Li ETS. Bitter melon (Momordica charantia) reduces adiposity, lower serum insulin and normalizes glucose tolerance in rats fed a high fat diet. J Nutr 133:1088-1093;2003.
7. Chinetti G, Fruchart JC, Staels B. Peroxisome proliferator-activated receptors (PPARs): Nuclear receptors at the crossroads between lipid metabolism and inflammation. Inflamm Res 49:497-505;2000.
8. Dallongeville J, Bauge E, Tailleux A, Peters JM, Gonzalez FJ, Fruchart JC, Staels B. Peroxisome proliferator-activated receptor alpha is not-limiting for the lipoprotein-lowering action of fish oil. J Biol Chem 276:4634-4639; 2001.
9. Desvergne B, Wahli W. Peroxisome proliferator-activated receptors: Nuclear control of metabolism. Endocr Rev 20:649-688;1999.
10. Dhar P, Ghosh S, Bhattacharyya DK. Dietary effects of conjugated octadecatrienoic fatty acid (9 cis, 11 trans, 13 trans) levels on blood lipids and nonenzymatic in vitro lipid peroxidation in rats. Lipids 34:109-114;1999.
11. Ellinghaus P, Wolfrum C, Assmann G, Spener F, Seedorf U. Phytanic acid activates the peroxisome proliferator-activated receptor α (PPARα) in sterol carrier protein 2-/ sterol carrier protein x-deficient mice. J Biol Chem 274: 2766-2772;1999.
12. Heim M, Johnson J, Boess F, Bendik I, Weber P, Hunziker W, Fluhmann B. Phytanic acid, a natural peroxisome proliferator-activated receptor (PPAR) agonist, regulates glucose metabolism in rat primary hepatocytes. FASEB J 16:718-720;2002.
13. Henke BR, Blanchard SG, Brackeen MF, Brown KK, Cobb JE, Collins JL, Harrington WW, Hashim MA, Hull-Ryde EA, Kaldor I, Kliewer SA, Lake DH, Leesnitzer LM, Lehmann JM, Lenhard JM, Orband-Miller LA, Miller JF, Mook RA, Noble SA, Oliver W, Parks DJ, Plunket KD, Szewczyk JR, Willson TM. N-(2-benzoylphenyl)-L-tyrosine PPARγ agonists. 1. Discovery of a novel series of potent antihyperglycemic and antihyperlipidemic agents. J Med Chem 41:5020-5036;1998.
14. Higashino H, Suzuki A, Tanaka Y, Pootakham K. Hypoglycemic effects of Siamese Momordica charantia and Phyllanthus urinaria extracts in streptozotocin-induced diabetic rats. Nippon Yakurigaku Zasshi 100:415-421;1992.
15. Huang CJ, Feltkamp D, Nilsson S, Gustafsson JA. Synergistic activation of RLD-1 by agents triggering PKA and PKC dependent signalling. Biochem Biophys Res Commun 243:657-663; 1998.
16. 2 production by a macrophage cell line. J Biomed Sci 9:596-606; 2002.
17. Jayasooriya AP, Sakono M, Yukizaki C, Kawano M, Yamamoto K, Fukuda N. Effects of Momordica charantia powder on serum glucose levels and various lipid parameters in rats fed with cholesterol-free and cholesterol-enriched diets. J Ethnopharmacol 72:331-336; 2000.
18. Karunanayake EH, Welihinda J, Sirimanne SR, Sinnadorai G. Oral hypoglycemic activity of some medicinal plants of Sri Lanka. J Ethnopharmacol 11:223-231;1984.
19. Kersten S, Desvergne B, Wahli W. Roles of PPARs in health and disease. Nature 405:421-424;2000.
20. Khanna P, Jain SC, Panagariya A, Dixit VP. Hypoglycemic activity of polypeptide-P from a plant source. J Nat Prod 44:648-655;1981.
21. Kimura Y, Minami Y, Tokuda T, Nakajima S, Takagi S, Funatsu G. Primary structures of N-linked oligosaccharides of momordin-a, a ribosome-inactivating protein from Momordica charantia seeds. Agric Biol Chem 55:2031-2036;1991.
22. Kohno H, Suzuki R, Noguchi R, Hosokawa M, Miyashita K, Tanaka T. Dietary conjugated linolenic acid inhibits azoxymethane-induced colonic aberrant crypt foci in rats. Jpn J Cancer Res 93:133-142;2002.
23. Leatherdale BA, Panesar RK, Singh G, Atkins TW, Bailey CJ, Bignell AHC. Improvement in glucose tolerance due to Momordica charantia (Karela). Br Med J 282:1823-1824;1981.
24. Lee-Huang S, Huang PL, Chen HC, Bourinbaiar A, Huang HI, Kuang HF. Anti-HIV and anti-tumor activities of recombinant MAP30 from bitter melon. Gene 161:151-156;1995.
25. Li Y, Matsuda H, Yamahara J, Yoshikawa M. Acceleration of gastrointestinal transit by momordin Ic in mice: Possible involvement of 5-hydroxytryptamine, 5-HT(2) receptors and prostaglandins. Eur J Pharmacol 392:71-77; 2000.
26. Matsuda H, Li Y, Murakami T, Matsumura N, Yamahara J, Yoshikawa M. Antidiabetic principles of natural medicines. III. Structure-related inhibitory activity and action mode of oleanolic acid glycosides on hypoglycemic activity. Chem Pharm Bull 46:1399-1403;1998.
27. Meir P, Yaniv Z. An in vitro study on the effects of Momordica charantia on glucose uptake and glucose metabolism in rats. Planta Med 51:12-16;1985.
28. Miura T, Itoh C, Iwamoto N, Kato M, Kawai M, Park SR, Suzuki I. Hypoglycemic activity of the fruit of the Momordica charantia in type 2 diabetic mice. J Nutr Sci Vitaminol 47:340-344;2001.
29. Moya-Camarena SY, Vanden Heuvel JP, Blanchard SG, Leesnitzer LA, Belury MA. Conjugated linoleic acid is a potent naturally occurring ligand and activator of PPARα. J Lipid Res 40:1426-1433;1999.
30. Murakami T, Emoto A, Matsuda H, Yoshikawa M. Medicinal foodstuffs. XXI. Structures of new cucurbitane-type triterpene glycosides, goyaglycosides-a, -b, -c, -d, -e, -f, -g, and -h, and new oleanane-type triterpene saponins, goyasa-ponins I, II, and III, from the fresh fruit of Japanese Momordica charantia L. Chem Pharm Bull 49:54-63;2001.
31. Peters JM, Hennuyer N, Staels B, Fruchart JC, Fievet C, Gonzalez FJ, Auwerx J. Alterations in lipoprotein metabolism in peroxisome proliferator-activated receptor α-deficient mice. J Biol Chem 272:27307-27312;1997.
32. Pu Z, Lu BY, Liu WY, Jin SW. Characterization of enzymatic mechanism of gamma-momorcharin, a novel ribosome-inactivating protein with lower molecular weight of 11,500 purified from the seeds of bitter gourd (Momordica charantia). Biochem Biophys Res Commun 229:287-294;1996.
33. Rosen ED, Spiegelman BM. PPARγ: A nuclear regulator of metabolism, differentiation, and cell growth. J Biol Chem 276:37731-37734;2001.
34. Sarkar S, Pranava M, Marita R. Demonstration of the hypoglycemic action of Momordica charantia in a validated animal model of diabetes. Pharmacol Res 33:1-4;1996.
35. Schluter A, Barbera MJ, Iglesias R, Giralt M, Villarroya F. Phytanic acid, a novel activator of uncoupling protein-1 gene transcription and brown adipocyte differentiation. Biochem J 362:61-69;2002.
36. Schoonjans K, Staels B, Auwerx J. Role of the peroxisome proliferator-activated receptor (PPAR) in mediating the effects of fibrates and fatty acids on gene expression. J Lipid Res 37: 907-925;1996.
37. Shibib BA, Khan LA, Rahman R. Hypoglycemic activity of Coccinia indica and Momordica charantia in diabetic rats: Depression of the hepatic gluconeogenic enzymes glucose-6-phosphatase and fructose-1,6-bisphosphatase and elevation of both liver and red-cell shunt enzyme glucose-6-phosphate dehydrogenase. Biochem J 292:267-270;1993.
38. Small GM, Burdett K, Connock MJ. A sensitive spectrophotometric assay for peroxisomal acyl-CoA oxidase. Biochem J 227:205-210; 1985.
39. Srivastava Y, Venkatakrishna-Bhatt H, Verma Y, Venkaiah K, Raval BH. Antidiabetic and adaptogenic properties of Momordica charan-tiaextract: An experimental and clinical evaluation. Phytother Res 7:285-289;1993.
40. Suzuki R, Arato S, Noguchi R, Miyashita K, Tachikawa O. Occurrence of conjugated linolenic acid in flesh and seed of bitter gourd. J Oleo Sci 50:753-758;2001.
41. Torra IP, Chinetti G, Duval C, Fruchart JC, Staels B. Peroxisome proliferator-activated receptors: From transcriptional control to clinical practice. Curr Opin Lipidol 12:245-254; 2001.
42. Welihinda J, Karunanayake EH. Extra pancreatic effects of Momordica charantia in rats. J Ethnopharmacol 17:247-255;1986.
43. Willson TM, Lambert MH, Kliewer SA. Peroxisome proliferator-activated receptor γ and metabolic disease. Annu Rev Biochem 70:341-367;2001.
44. 2 production of a macrophage cell line by some phytochemicals. Food Sci Agric Chem 3: 59-71;2001.